Infar Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.30 M
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.00 Cr
- Satisfied Charges ₹ 9.75 Cr
- Revenue Growth 29.15%
- Profit Growth -5.69%
- Ebitda -118.91%
- Net Worth 6.19%
- Total Assets 6.02%
About Infar Healthcare
Infar Healthcare Private Limited (IHPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 May 2008 and has a history of 16 years and nine months. Its registered office is in Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹9.00 Cr. The company has closed loans amounting to ₹9.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Geeta Goel and Pinki Goel serve as directors at the Company.
Company Details
-
Location
Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232DL2008PTC177515
-
Company No.
177515
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 May 2008
-
Date of AGM
10 Aug 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Infar Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Geeta Goel
|
Director | 06-Jun-2014 | Current |
|
Pinki Goel
|
Director | 06-Jun-2014 | Current |
Financial Performance of Infar Healthcare.
Infar Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.15% increase. The company also saw a slight decrease in profitability, with a 5.69% decrease in profit. The company's net worth moved up by a moderate rise of 6.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Infar Healthcare?
In 2023, Infar Healthcare had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Medial Pharma LimitedGeeta Goel and Pinki Goel are mutual person
-
Astra Medica Private Limited
Geeta Goel and Pinki Goel are mutual person
Charges (Loans)
₹90.00 M
₹97.50 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 9.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Apr 2021 | Hdfc Bank Limited | ₹9.00 Cr | Open |
| 04 Jun 2012 | Axis Bank Limited | ₹9.75 Cr | Satisfied |
How Many Employees Work at Infar Healthcare?
Unlock and access historical data on people associated with Infar Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Infar Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Infar Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
